U.S. Markets closed

Biotech stocks are getting slammed by earnings and Trump's Tweets: NYSE trader

Keith Bliss of Cuttone and Company joins Yahoo Finance's Justine Underhill from the floor of the New York Stock Exchange to discuss the latest earnings from Merck and Gilead, as well as what's in store for the biotech industry.